| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 430.86B | 460.51B | 441.71B | 409.20B | 349.96B | 346.15B |
| Gross Profit | 54.92B | 62.97B | 59.85B | 53.41B | 54.24B | 57.48B |
| EBITDA | 30.65B | 35.10B | 35.08B | 30.70B | 36.99B | 47.82B |
| Net Income | 5.17B | 8.63B | 10.21B | 5.34B | 12.42B | 20.74B |
Balance Sheet | ||||||
| Total Assets | 425.89B | 432.37B | 446.21B | 416.23B | 415.99B | 390.48B |
| Cash, Cash Equivalents and Short-Term Investments | 77.45B | 111.54B | 150.75B | 132.91B | 139.59B | 158.40B |
| Total Debt | 6.50B | 5.76B | 4.66B | 4.82B | 6.03B | 5.23B |
| Total Liabilities | 99.35B | 106.68B | 97.51B | 92.77B | 90.40B | 89.03B |
| Stockholders Equity | 309.53B | 306.30B | 326.93B | 298.79B | 296.86B | 277.02B |
Cash Flow | ||||||
| Free Cash Flow | -11.49B | 11.72B | 24.60B | 17.01B | 6.24B | 19.70B |
| Operating Cash Flow | 8.18B | 28.71B | 37.66B | 30.45B | 20.02B | 25.15B |
| Investing Cash Flow | -22.57B | -35.87B | -8.73B | -20.52B | -16.57B | -11.76B |
| Financing Cash Flow | -21.59B | -31.44B | -17.75B | -19.31B | -24.26B | -14.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥71.44B | 7.00 | 11.87% | 5.00% | -10.87% | 153.16% | |
75 Outperform | ¥482.87B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
74 Outperform | ¥505.73B | 11.33 | ― | 2.60% | 1.06% | -5.99% | |
66 Neutral | ¥434.10B | 10.02 | 3.70% | 3.42% | 2.10% | -50.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥214.80B | 16.01 | ― | 4.77% | -3.71% | -51.81% | |
54 Neutral | ¥1.67T | 14.23 | 8.34% | 2.03% | 4.33% | 524.86% |